Lysine-Proline-Valine (KPV)

KPV Compound Overview

KPV is a tripeptide identified by the Lysine-Proline-Valine sequence and KPV abbreviation. This page identifies the material as KPV (Lys-Pro-Val), with amino acid count 3; synonyms α-MSH(11-13); Lys-Pro-Val. The KPV identifiers distinguish this catalogue entry from similarly named compounds, fragments, modified analogues, and multi-component formulations.

Tripeptide Research Context

The research record for KPV is organized around tripeptide characterization, sequence-based peptide research, signaling-pathway literature, and analytical peptide workflows. For KPV, those subjects define the literature and analytical context of this specific research peptide; they do not establish a clinical indication, administration route, or expected outcome.

Available KPV Specifications

The live selector currently lists 5mg, 10mg for KPV, supplied as 10 Vials. Each selectable KPV specification retains its own SKU, displayed price, inventory record, and matched image, so the chosen option can be checked without relying on a generic dose range.

KPV Identity & Composition

Record boundary: Molecular identifiers describe the named KPV form; lot-specific analytical results remain in the matched COA record.

How to Read the KPV COA

NOVABIO currently displays 2 matched certificate records for KPV, covering 10 mg. The newest listed record is batch NV-KPV10-0628, tested Aug 10, 2026, with reported purity 99.07% and net content 10.51 mg. The NV-KPV10-0628 record also lists heavy metals: Pass; endotoxins: Pass; sterility: Pass. For KPV, match the selected specification and batch number to the displayed certificate; results from one lot are not generalized to every variant.

Research Use Notice

This material is supplied for controlled laboratory and research use only. It is not intended for human or animal consumption, diagnosis, treatment, administration, or therapeutic use. Buyers should review the selected specification and its matched documentation before ordering.